Health startup Field Intelligence embarks on expansion drive across Nigeria and Kenya

Health tech startup Field Intelligence has recently announced a significant expansion of its operations, spreading across seven states in Nigeria and four cities in Kenya. This move comes as the company looks to enhance its reach and impact in the healthcare sector, particularly focusing on improving pharmacy services for millions of patients. With over 700 pharmacy memberships under its belt, Field Intelligence is now serving approximately 1.4 million patients with its innovative supply chain financial solution. The company's CEO, Michael Moreland, recently sat down with CNBC Africa to shed light on the rationale behind their model and the future prospects for the health tech space in Nigeria and beyond. Moreland highlighted the critical role that pharmacies play in providing healthcare access, especially in regions like Nigeria and Kenya. Acknowledging the challenges that these small businesses face, particularly in managing pharmaceutical complexities, Moreland emphasized how Field Intelligence's model aims to alleviate these burdens and empower pharmacies to deliver better services to their patients. The company's unique approach involves streamlining supply chain processes and offering a financial solution that enables pharmacies to grow and optimize their operations. When questioned about the expansion plans in Nigeria, Moreland shared insights into their decade-long presence in the country's health sector and Field Intelligence's strategic entry into seven chosen states. He emphasized the importance of supporting community-based pharmacies, especially amidst the pandemic, where these frontline healthcare providers have been pivotal in meeting diverse medical needs. Moreland underscored how Field Intelligence's supply chain outsourcing model has helped pharmacies navigate the challenges posed by the pandemic, ensuring continuity of services and flexibility in managing inventory costs. As the conversation delved into the role of local drug manufacturers in the company's strategy, Moreland highlighted the increasing collaboration with domestic manufacturers. He pointed out the benefits of sourcing from trusted local brands, which offer price stability and reliable supply amidst currency fluctuations. With a focus on product categories gaining traction, Moreland highlighted the demand for essential drugs, including antibiotics and antimalarials, alongside a growing interest in non-communicable disease treatments and consumer healthcare products. The CEO also discussed the shift towards prevention and wellness products in response to evolving consumer preferences. Looking ahead, Moreland expressed optimism about the long-term growth potential of the health tech space, particularly in digitizing healthcare infrastructure and expanding quality services across Africa. He emphasized the collaborative efforts of various stakeholders in driving innovation and accessibility in the healthcare sector. On the topic of future expansion plans, Moreland affirmed the company's commitment to scaling its services across East and West Africa, leveraging a scalable and asset-light model. He highlighted the universality of the challenges faced by pharmacies in different regions, underscoring the commonalities in addressing supply chain efficiencies and financial constraints. Despite regional nuances, Moreland emphasized the shared need for enhanced pharmacy solutions across diverse markets. In comparing outcomes between East and West Africa, particularly Kenya and Nigeria, Moreland noted that while there are differences in disease burdens and currency dynamics, the fundamental challenges of pharmacy operations remain consistent. He stressed the importance of recognizing the commonalities in addressing supply chain complexities and improving access to quality healthcare services across the continent. As Field Intelligence continues its expansion drive, the company remains poised to make a significant impact on the healthcare landscape, driving innovation and efficiency in pharmacy operations for the benefit of millions of patients.